Trial intelligence / Profile preview

Juvista for Scar Improvement in Varicose Vein Surgery

NCT00430326Phase 2Completed

Sponsor
Renovo
Start
Nov 2006
Primary completion
Jan 2009
Modality
Recombinant Proteins and Enzymes
Countries
4
01

Overview

A Phase 2 trial of avotermin in cicatrix, sponsored by Renovo. Started Nov 2006; status: completed.

02

Drugs

avotermin
03

Conditions

cicatrix

Beyond the preview

Go deeper on NCT00430326.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00430326.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call